{
  "symbol": "BBNX",
  "company": "Beta Bionics, Inc.",
  "generated_at": "2026-06-24T07:36:45.565Z",
  "event_count": 3,
  "events": [
    {
      "type": "pipeline_event",
      "ts": "2026-06-03T22:30:21.076Z",
      "stage": "analyst",
      "outcome": "skip",
      "reason": "Composite score of 19 falls well below the 45-point threshold. The 'going_concern' anti-signal is mitigated by a ~10-quarter cash runway ($239M vs $24M/q burn), and dilution is manageable via RSUs, but the dossier lacks verified insider purchases, concrete valuation metrics, and specific option chain data required to construct the suggested income structures safely. The stock remains below its 200DMA with unverified flow, making it a low-conviction candidate.",
      "trigger": "[insider_cluster_universe] 4 Form 4 filings in last 14 days · at least one open-market P/S trade verified",
      "source": "idle_hunter"
    },
    {
      "type": "analyst_decision",
      "ts": "2026-06-03T22:30:21.059Z",
      "skip": true,
      "reason": "Composite score of 19 falls well below the 45-point threshold. The 'going_concern' anti-signal is mitigated by a ~10-quarter cash runway ($239M vs $24M/q burn), and dilution is manageable via RSUs, but the dossier lacks verified insider purchases, concrete valuation metrics, and specific option chain data required to construct the suggested income structures safely. The stock remains below its 200DMA with unverified flow, making it a low-conviction candidate.",
      "score": 19,
      "breakdown": {
        "smart_money": 0,
        "options_flow": 0,
        "catalyst": 10,
        "mispricing": 0,
        "quality": 5,
        "technical": 4
      },
      "debug_path": "drafts/2026-06-03-BBNX.analyst.debug.json"
    },
    {
      "type": "scout_dossier",
      "ts": "2026-06-03T22:29:09.463Z",
      "summary": "Beta Bionics is a commercial-stage medtech company with the FDA-cleared iLet Bionic Pancreas for Type 1 diabetes. The stock has collapsed ~62% from its 52-week high of $32.71 (near-IPO levels) following an analyst day selloff in January 2026, while the Q1 2026 earnings report showed strong fundamental performance: $27.6M net sales (+57% YoY), gross margin expansion to ~59%, and full-year guidance raised. The trigger cluster is a dense cluster of Form 4 filings on two dates (May 26 with report date May 21, and June 3 with report date June 2) — though transaction codes couldn't be verified via XML due to EDGAR URL issues. The stock is below its 200-day MA, which is an anti-signal for long conviction. Earnings are July 21, 2026 (within the catalyst window). Mint patch pump targeting Insulet expected end-Q2 2027. Cash position of ~$239M vs. market cap of $555M gives meaningful buffer against dilution risk.",
      "verdict": "range_bound_or_income",
      "confidence": 3,
      "tool_calls": 21,
      "walltime_min": 14,
      "debug_path": "dossiers/2026-06-03-BBNX.scout.debug.json"
    }
  ],
  "lessons": [],
  "chart_signal": {
    "ticker": "BBNX",
    "call": "SELL",
    "confidence": 3,
    "score": -7,
    "factors": {
      "below_200dma": "-2",
      "above_50dma": "+1",
      "momentum_strong_down": "-2 (-32.5%)",
      "rsi_neutral": "0 (57.6)",
      "recent_macd_bearish_cross": "-2 (2d ago)",
      "broken_below_high": "-2 (-57.3% from high)"
    },
    "summary": "SELL (score -7) · 12-1 mom -32.5% · RSI 57.6 · above_50_only · -57.3% from high",
    "last_close": 13.67,
    "one_month_ago_close": 10.61,
    "twelve_month_ago_close": 15.72,
    "twelve_one_momentum_pct": -32.51,
    "rsi_14": 57.6,
    "ma_stack": "above_50_only",
    "from_period_high_pct": -57.27,
    "period_high": 31.99,
    "price_targets": {
      "bear": 13,
      "fair": 14.88,
      "bull": 36.79,
      "bear_return_pct": -4.9,
      "fair_return_pct": 8.9,
      "bull_return_pct": 169.1,
      "method": "street_targets ⨯ chart_floors",
      "street": {
        "target_low": 13,
        "target_mean": 19.18182,
        "target_high": 32,
        "analyst_count": 11
      }
    },
    "generated_at": "2026-06-24T07:36:45.561Z"
  }
}